32 Plasmacytoid DCs control HIV latency in resting T cells by type I IFNα

• R.M. Van der Sluis,
• T. Mota,
• N.A. Kumar,
• V.A. Evans,
• A.N. Harman,
• S. Tennakoon,
• S.G. Deeks,
• P. Herzog,
• S.R. Lewin,
• P.U. Cameron

Affiliations

R.M. Van der Sluis

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia

T. Mota

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia

N.A. Kumar

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia

V.A. Evans

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia

A.N. Harman

Centre for Virus Research, Westmead Millennium Institute, Westmead, New South Wales, Australia

S. Tennakoon

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia

S.G. Deeks

Department of Medicine, UCSF School of Medicine, San Francisco, CA, USA

P. Herzog

Hudson Institute of Medical Research, Clayton, Victoria, Australia

S.R. Lewin

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia; Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Australia

P.U. Cameron

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia; Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Australia